Order Article Reprints

Chang S-F, Chen C-N, Lin J-C, Wang H-E, Mori S, Li J-J, Yen C-K, Hsu C-Y, Fung C-P, Chong PC-S, et al. Truncated Pneumolysin from Streptococcus pneumoniae as a TLR4-Antagonizing New Drug for Chronic Inflammatory Conditions. Cells. 2020; 9(5):1183. https://doi.org/10.3390/cells9051183

Chang, Shun-Fu, Cheng-Nan Chen, Jung-Chung Lin, Hsin-Ell Wang, Shigetarou Mori, Jia-Je Li, Chia-Kuang Yen, Ching-Yun Hsu, Chang-Phone Fung, Pele Choi-Sing Chong, and et al. 2020. "Truncated Pneumolysin from Streptococcus pneumoniae as a TLR4-Antagonizing New Drug for Chronic Inflammatory Conditions" Cells 9, no. 5: 1183. https://doi.org/10.3390/cells9051183

Chang, S.-F., Chen, C.-N., Lin, J.-C., Wang, H.-E., Mori, S., Li, J.-J., Yen, C.-K., Hsu, C.-Y., Fung, C.-P., Chong, P. C.-S., Leng, C.-H., Ding, Y.-J., Chang, F.-Y., & Siu, L. K. (2020). Truncated Pneumolysin from Streptococcus pneumoniae as a TLR4-Antagonizing New Drug for Chronic Inflammatory Conditions. Cells, 9(5), 1183. https://doi.org/10.3390/cells9051183